ReviewSleep science (Sao Paulo, Brazil)2026
REM Sleep Behavior Disorder as a Key Predictor of Cognitive Decline: Insights from a Narrative Review.
Review in Sleep science (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia. Mounting evidence positions RBD as a critical prodromal indicator of synucleinopathies-particularly Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA)-with a significant link to progressive cognitive decline. Objective: To explore the underlying pathophysiological mechanisms connecting RBD with cognitive impairment, to delineate the neuropsychological profile of the affected individuals, and to critically evaluate the current diagnostic tools and therapeutic challenges. Materials and Methods: We synthesized data from clinical cohort studies, structural and functional neuroimaging modalities (magnetic resonance imaging [MRI], fluorodeoxyglucose positron-emission tomography [FDG-PET], and single-photon emission computed tomography [SPECT]), molecular biomarkers-including alpha-synuclein seeding assays-and genetic studies focusing on mutations such as Results: Individuals with idiopathic RBD (iRBD) frequently exhibit early deficits in executive function, attention, visuospatial abilities, and episodic memory-often years before motor symptoms manifest. Pathologically, the spread of alpha-synuclein aggregates from REM sleep-regulating nuclei in the brainstem to limbic and neocortical areas mirrors the trajectory of cognitive decline. Cholinergic-system degeneration, particularly in the pedunculopontine nucleus and basal forebrain, further contributes to the neurocognitive symptoms. Neuroimaging consistently reveals frontal and temporal cortical thinning, along with posterior hypometabolism characteristic of synucleinopathies. Biomarker analysis shows altered cerebrospinal fluid (CSF) amyloid-beta and -tau levels, as well as positive alpha-synuclein real-time quaking-induced conversion (RT-QuIC) assay results. Genetic predispositions strongly influence the risk and rate of progression. Conclusion: A powerful early biomarker for cognitive decline associated with synucleinopathies, the early identification of RDB through comprehensive neuropsychological profiling, advanced imaging techniques, and molecular diagnostic methods is essential for risk stratification and monitoring. Although disease-modifying therapies remain elusive, a deeper understanding of shared pathogenic pathways offers promising avenues for targeted neuroprotective strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.